From quarterly updates to key announcements, here you can access all GSK investor-related information.
Scroll to explore
We’re confident in our future
Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery over the next five years.
Latest announcements and results
2022 Full year and fourth quarter results announcementQuarterly results
We announced our full year and fourth quarter results for the period which ended 31 December 2022 on Wednesday 1 February.
GSK publishes Prospectus and CircularPress release
We have published the Prospectus and Circular for the proposed demerger of our Consumer Healthcare business to form Haleon.
Completion of the demerger of Haleon and share consolidation of GSKPress release
GSK plc has today completed the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group.
Completion of GSK Share ConsolidationPress release
GSK plc is pleased to announce that further to the Circular and Notice of General Meeting published by GSK on 1 June 2022, and following the announcements of 6 July 2022 that shareholder approval was granted at the GSK General Meeting and of 18 July 2022 that GSK has completed the demerger of the Consumer Healthcare business from the GSK Group to form Haleon.
Speeches and presentations
Dividend and share price
Q1 2023 results
We will announce our first quarter 2023 results on Wednesday 26 April.
Q2 2023 results
We will announce our second quarter 2023 results on Wednesday 26 July.
q3 2023 results
We will announce our third quarter 2023 results on Wednesday 01 November.